User:LBcontat/sandbox

Labiotech.eu is Europe's largest digital media platform covering the news in the biotechnology industry. It covers the biotechnological point of view of clinics, law, finances, industry, and bio art and has the largest online audience for a biotech media in Europe. The office is located in Berlin with 15 members in the team, including the CEO and co-founders, Philip Hemme and Joachim Eeckhout. Labiotech.eu has completed projects such as the Labiotech Tour, Labiotech Map and most recently Labiotech.eu.

History
Labiotech.eu was launched in September 2014 and is based in Berlin, Germany. Founded by Philip Hemme and Joachim Eeckhout, the two started work together on a blog about biotechnology in France, which became successful in 2012. They continued with a different project, LabiotechTour, the first World Tour of the Biotech ecosystem, from the summer of 2014 to 2016. They traveled to eight destinations (France, Boston, Ireland, Germany, the UK, Denmark, India and SF Bay area) to cover the biotech ecosystem through a series of company documentaries.

Awards
In 2016 and 2017, Labiotech.eu was nominated for the Media commentator of the year at European Mediscience Awards. In 2016 the nomination was alongside Fierce Biotech, the Financial Times and BioCentury, and in 2017 alongside The Telegraph, Endpoints News and the Financial Times.

Products
The LabiotechMap is an interactive map of Europe where over 1,000 companies in the biotech industry can be found. This ranges from large biotech's to startups who meet certain criteria. To meet these criteria the company must own an innovate technology in the field and have raised or generated over €1M. Provided information includes a brief description of the company, the number of employees, the financial data, foundation date, and contact information.

Fundraising
Labiotech.eu has had two rounds of fundraising to date. The first seed fundraiser in 2016 was raised with the lead investor WestTech Ventures as well as Sven Fund, Bertrand Landel, Simon Bungers, Michel Lurquin and the company Adveris. The funds were directed to produce high-quality content, develop new content formats and to organise the first of the Labiotech Refresh conferences.

The second round of fundraising in 2017 was once again raised with the help of lead investor WestTech Ventures, as well as a second lead investor, Wille AG, and two further individual sponsors.